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Abstract
Introduction: Intervertebral disc (IVD) degeneration is associated with proteolytic degradation of the extracellular
matrix, and its repair requires both the production of extracellular matrix and the downregulation of proteinase
activity. These properties are associated with several growth factors. However, the use of growth factors in clinical
practice is limited by their high cost. This cost can be circumvented using synthetic peptides, such as Link N,
which can stimulate the synthesis of proteoglycan and collagen by IVD cells in vitro. The purpose of the present
study was to evaluate the effect of Link N in vivo in a rabbit model of IVD degeneration.
Methods: New Zealand white rabbits received annular puncture in two lumbar discs. Two weeks after puncture,
both punctured discs of each rabbit were injected with either Link N or saline. After 2 weeks, nine rabbits were
euthanized and the annulus fibrosus (AF) and nucleus pulposus (NP) of Link N-injected and saline-injected IVDs
were removed and used to prepare total RNA. Following reverse transcription, quantitative PCR was performed for
aggrecan, COL2A1, COL1A1, ADAMTS-4, ADAMTS-5 and MMP-3. After 12 weeks, 19 rabbits were euthanized and
the injected IVDs were removed for biochemical and histological analysis. Proteinase K digests were analyzed for
DNA and sulfated glycosaminoglycan content. Disc height was monitored radiographically biweekly.
Results: Following needle puncture, disc height decreased by about 25% over 2 weeks, and was partially restored
by Link N injection. Puncture of the IVD resulted in a trend towards decreased proteoglycan content in both the
NP and AF, and a trend towards partial restoration following Link N injection, although under the time course used
this did not achieve statistical significance. Link N did not alter the DNA content of the discs. Link N injection led
to a significant increase in aggrecan gene expression and a significant decrease in proteinase gene expression in
both the NP and AF, when compared with saline alone.
Conclusions: When administered to the degenerate disc in vivo, Link N stimulated aggrecan gene expression and
downregulated metalloproteinase expression, and there was a trend towards increased proteoglycan content of
the disc, in both the NP and AF. These are features needed for any agent designed to stimulate disc repair. In
principle, therefore, Link N supplementation could be an option for treating disc degeneration.
Introduction
Low back pain is an insidious disorder that, by age 70,
affects about 60% of the population. Although the etiol-
ogy of low back pain is often unclear, it is believed that
intervertebral disc (IVD) degeneration plays a major role
[1,2]. While present management of disc pathology has
been focused on symptoms associated with degenera-
tion, fewer studies have been devoted to disc
regeneration. Current surgical procedures such as disc
excision and vertebral fusion [3] lead to relief of pain in
the short term, but they alter the biomechanics of the
spine, leading to further degeneration of surrounding
tissue and discs at adjacent levels. Newer treatment
methods such as artificial disc implants are controver-
sial, as their insertion partially disrupts the disc struc-
ture and may eventually destabilize the motion segment.
Procedures to invoke biological repair of the degenerate
disc could help resolve these concerns.
Discs allow bending and twisting of the spine whilst
resisting compression from gravity and muscle action
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[4]. The discs are thought to resist compressive forces
by their high content of the proteoglycan aggrecan,
which interacts with hyaluronate to produce large pro-
teoglycan aggregates, with each interaction being stabi-
lized by the further interaction of a link protein [5,6].
The proteoglycan aggregates induce a high swelling
pressure in the nucleus pulposus (NP) that is balanced
by tensile forces produced in the collagen network of
the annulus fibrosus (AF). Disc degeneration is asso-
ciated with biochemical alterations in the composition
and structure of the extracellular matrix (ECM) due to
depleted synthesis and increased degradation, with
aggrecan being particularly susceptible to proteolytic
damage and loss. While poor IVD nutrition may be a
major contributor to disc degeneration, biomechanical
[7-9], biochemical [10-15] and genetic [16,17] influences
may also play a role in some individuals. The degenerate
discs have little capacity for endogenous repair because
of their lack of blood vessels and poor nutrition. Indu-
cing repair of disc tissue may be possible, however, as
the use of chymopapain to degrade the degenerate NP
can stimulate new ECM formation [18,19], although not
consistently. Cell or growth factor therapies have also
recently been suggested to induce IVD repair [20-24].
The stimulation of repair in the degenerate IVD
requires both the production of ECM and the downre-
gulation of proteinase activity. Matrix synthesis is asso-
ciated with several growth factors, including
transforming growth factor beta and bone morphoge-
netic protein 7 [25-28] However, one problem with the
use of growth factors in clinical practice is their high
cost. In principle this can be circumvented using syn-
thetic peptides, which are relatively cheap to produce.
One peptide with the ability to stimulate ECM synth-
esis and therefore possessing growth factor-like prop-
erties is Link N [29-31]. Link N (DHLSDNY
TLDHDRAIH) is the N-terminal peptide of the link
protein that stabilizes the proteoglycan aggregates.
This peptide is generated in vivo by proteolytic degra-
dation during tissue turnover [32]. Previous studies
showed that Link N can stimulate synthesis of proteo-
glycans and collagens in articular cartilage [29,33,34].
Link N can also preferentially stimulate the synthesis
of proteoglycan over collagen by bovine IVD cells in
vitro, without any effect on cell division [30]. To date,
however, there have been no reports on the effect of
Link N on the IVD in vivo. The purpose of the present
study was to determine the effect of intradiscally admi-
nistered Link N on disc cell survival and whether Link
N can stimulate ECM production and downregulate
proteinase production in a rabbit annular needle punc-
ture model of IVD degeneration.
Materials and methods
Synthesis of Link N
Link N was synthesized with a purity > 98% by CanPep-
tide Inc. (Pointe-Claire, QC, Canada).
Rabbit annular puncture model and Link N injection
Thirty-eight New Zealand white rabbits weighing
approximately 3.5 kg (5 to 6 months old) were used in
the present study with the approval of the Institutional
Animal Care and Use Committee. Twenty-eight rabbits
received the annular puncture with an 18-gauge needle
and a 5 mm depth of puncture on two noncontiguous
discs (L2/L3 and L4/L5), as previously described [22,35].
Two weeks after the initial puncture, both previously
punctured discs of each rabbit were injected either with
saline (10 μl per disc) or with Link N (100 μg in 10 μl
saline per disc) through their anterolateral surfaces into
the center of the NP using a 26-gauge needle. Ten rab-
bits, which were not punctured and remained untreated,
were used as a control group for biochemical analysis
and histologic evaluation.
Radiographic analysis of disc height
Radiographs were taken using a digital radiography sys-
tem (resolution 71 μm; NAOMI, Nagano, Japan) after
administration of ketamine hydrochloride (25 mg/kg)
and acepromazine maleate (1 mg/kg), at biweekly inter-
vals up to 12 weeks after the puncture. The preoperative
radiograph, which was imaged 2 or 3 days before the
surgery, was always used as a baseline measurement. A
strict protocol was used to obtain optimal images for
the image analysis, as previously described [35]. To
decrease the error from axial rotation of the spine and
from beam divergence, radiographs were repeated until
a reasonable alignment of transverse processes (within
one-half width of processes as a deviation) was achieved
on each animal in the lateral decubitus position with the
beam centered 4 cm from the rabbit iliac crest.
Analysis of disc height was performed, as previously
described, with further normalization to the L3/L4 disc
[35]. All radiograph images were digitized and indepen-
dently analyzed using a custom program for MATLAB
software (Natick, MA, USA) by an orthopedic researcher
who was blinded to the treatment groups. The average
of the disc height index (DHI) was calculated as a ratio
of the average anterior, middle, and posterior IVD space
measurements to the average of the adjacent vertebral
body heights. Changes in the DHI of injected discs were
expressed as a percentage, and were calculated as pre-
viously described [35]:
%DHI = (postoperative DHI/preoperative DHI)× 100
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The %DHI was further normalized using the nonpunc-
tured L3/L4 level as a control in order to account for
the vertebral body growth:
Normalized %DHI = (experimental level %DHI/L3/L4 %DHI)× 100
Using this technique, the intraobserver error (percen-
tage coefficient of variance = 3.13%) and interobserver
error (percentage coefficient of variance = 9.6%) of DHI
measurements have been reported to be minimal [35].
RNA extraction and gene expression analyses
Nine rabbits were euthanized 2 weeks after either Link
N or saline injection, and the injected IVDs (L2/L3 and
L4/L5) from both experimental groups were removed
from each lumbar spine for gene expression analysis
(Table 1). After disc excision, the NP was bluntly sepa-
rated from the AF. Each tissue was snap-frozen and pul-
verized using a Cryopress (Microtech Ltd, Tokyo,
Japan). Total RNA was extracted from the pulverized
tissues using an RNeasy mini kit (Qiagen, Valencia, CA,
USA). After extraction, RNA was quantified using a
Nanodrop N-1000 spectrophotometer (Fisher Scientific,
Wilmington, DE, USA). One microgram of total RNA
from each AF or NP was reverse-transcribed into cDNA
using the Superscript™ First Strand cDNA synthesis kit
(Invitrogen, Carlsbad, CA, USA). Two microliters of
cDNA were amplified using gene-specific primers (Table
2). The PCR was carried out by denaturing at 95°C for
15 minutes, followed by annealing at 58 to 65°C for 30
seconds (Table 2), then extension at 72°C, repeated for
55 cycles using a SYBR green kit (Qiagen). All PCR
reactions were carried out using a Roche Light Cycler
(Roche Diagnostics, Indianapolis, IN, USA), and mRNA
expression was quantified using a standard curve gener-
ated with cloned cDNA plasmids containing target PCR
products. The expression of the target genes was first
normalized to GAPDH expression levels, and then the
expression of the Link N-treated discs was normalized
to saline-treated discs.
Biochemical analysis
Thirteen rabbits were euthanized 12 weeks after either
Link N or saline injection, and the injected IVDs (L2/L3
and L4/L5) from both experimental groups were
removed from each lumbar spine for biochemical
Table 1 Number of animals and discs used in the study
2 weeks after injection 12 weeks after injection Total
Rabbits (n) Discs (n) Rabbits (n) Discs (n) Rabbits (n) Discs (n)
Gene expression
Saline 4 8 9 18
Link N 5 10
Biochemistry
Control 6 12
Salinea 6 12 19 38
Link Na 7 14
Histology
Control 4 8
Saline 3 6 10 20
Link N 3 6
aThese rabbits were also used for biweekly X-ray measurements of disc height.
Table 2 Oligonucleotide primers used to assess gene
expression
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analysis (Table 1). Twelve discs from six additional con-
trol rabbits were also analyzed. After disc excision, the
NP was bluntly separated from the AF. All specimens
were weighed (wet weight) and digested with proteinase
K at 56°C for 48 hours. The content of DNA in the
digest was analyzed by a fluorometric DNA assay using
PicoGreen [36]. The data were normalized to a per disc
basis. Wet weight basis normalization was avoided
because of disc swelling. The proteinase K digests were
also analyzed for proteoglycan (predominantly aggrecan)
as sulfated glycosaminoglycan using the 1,9-dimethyl-
methylene blue dye-binding assay [37], and for hyaluro-
nate using a competitive hyaluronate-binding assay [38].
Histology
Six rabbits were euthanized 12 weeks after either Link
N or saline injection, and the injected IVDs (L2/L3
and L4/L5) from both experimental groups were
removed from each lumbar spine for histology (Table
1). Eight discs from four additional control rabbits
were also evaluated. The IVDs were excised and fixed
in 10% neutral buffered formalin solution, decalcified
in Plank Rychlo solution (Cal-Ex* II Fixative/Decalci-
fier, Fisher Scientific, Wilmington, DE, USA), dehy-
drated in a graded series of ethanol (70%, 90% and
99%), and processed individually for paraffin embed-
ding, as previously described [22]. The paraffin blocks
were sectioned longitudinally using a microtome to
give 5 μm sections. The paraffin sections were
dewaxed and stained with Safranin O to detect proteo-
glycan (predominantly aggrecan).
Statistical analysis
Statistical analysis was performed using the Statview
(version 5.0; SPSS, Chicago, IL, USA) program package.
Differences between the Link N-injected and saline-
injected groups were assessed with one-way repeated
analysis of variance and Fisher protected least significant
difference as a post hoc test.
Results
Radiographic assessment
The initial AF puncture with an 18-gauge needle to
initiate disc degeneration was performed identically in
both the saline and Link N groups. Following needle
puncture the normalized %DHI decreased by about
25% over the next 2 weeks compared with the baseline
DHI values obtained before puncture (Figure 1). By 4
weeks after the Link N injection, the mean normalized
%DHI of the injected discs in the Link N group was
higher than in the saline group. This difference in nor-
malized %DHI was maintained for the following 8
weeks with a statistically significant increase after 12
weeks (P < 0.05).
Aggrecan expression
Aggrecan message levels were examined following Link
N treatment because it is the major contributor to the
sulfated glycosaminoglycan content of the tissue and
hence is responsible for tissue swelling and function.
Furthermore, aggrecan loss is a feature of disc degenera-
tion, and its replacement is essential for repair. Link N
injection led to a significant increase (P < 0.001) in
aggrecan gene expression in both the AF and NP, when
compared with saline alone (Figure 2).
Collagen expression
Collagen message levels were examined following Link
N treatment because the collagen fibrils allow the IVD
to entrap the proteoglycan aggregates as well as provide
tensile strength to the tissue. Link N injection led to a
significant increase (P < 0.001) in type II collagen
(COL2A1) gene expression in the NP, when compared
with saline alone (Figure 2). Although there was a slight
increase in COL2A1 message in the AF, this was not
significant (P = 0.36). In contrast, Link N injection led
to a significant increase (P < 0.001) in type I collagen
(COL1A1) gene expression in the AF but a significant
decrease in the NP (P < 0.01) (Figure 2).
Proteinase expression
Since metalloproteinases, particularly members of the
ADAMTS and matrix metalloproteinase (MMP)
Figure 1 Changes in intervertebral disc height index after
annulus fibrosus puncture and injection. Changes in the
intervertebral disc height index (DHI) after the annulus fibrosus (AF)
puncture and saline or Link N injections. The DHI was measured at 2-
week intervals to quantify changes in disc height. Values represent
the mean normalized %DHI ± standard deviation of Link N-injected
and saline-injected discs at each time point. By 4 weeks after the Link
N injection, the mean normalized %DHI of injected discs in the Link
N group was higher than in the saline group. This difference was
maintained during the next 8 weeks. By 12 weeks after the Link N
injection, the mean normalized %DHI of injected discs in the Link N
group was significantly higher than in the saline group (*P < 0.05).
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families, are major contributors to aggrecan degradation
and loss in disc degeneration, MMP-3, ADAMTS-4 and
ADAMTS-5 message levels were also examined, as their
suppression is essential for disc repair. Link N injection
led to a significant decrease in MMP-3 (P < 0.001) and
ADAMTS-4 (P < 0.001) gene expression in both the AF
and NP tissues, when compared with saline alone (Fig-
ure 3). In contrast, Link N injection led to a significant
decrease in the gene expression of ADAMTS-5 in the
AF (P < 0.001) but an increase in NP tissues (P < 0.001)
when compared with saline alone (Figure 3).
DNA content
DNA was analyzed in order to determine the effect of Link
N on cell proliferation. AF puncture decreased the DNA
content of the discs and neither subsequent saline nor
Link N injection caused an increase in the DNA content
12 weeks after injection (Figure 4). Similar DNA contents
were observed for the NP although the saline group
appeared to be slightly higher than the Link N-injected
group. These changes were not statistically significant.
Proteoglycan content
Puncturing the IVD led to a decrease in proteoglycan
content in both the NP and the AF after 12 weeks in
saline-treated discs (Figure 4). Treatment with Link N
for 12 weeks following initiation of degeneration
resulted in increased proteoglycan content in both the
NP and AF by about 20%, when compared with saline-
treated discs. Similar changes were observed when the
sulfated glycosaminoglycan/DNA ratio was measured
(data not shown). However, these trends were not statis-
tically significant.
Hyaluronic acid content
The hyaluronic acid content was also monitored because
proteoglycan loss can also be associated with hyaluronic
Figure 2 Changes in aggrecan, type II collagen and type I
collagen gene expression. Changes in aggrecan (AGG), type II
collagen COL2A1 (COL II) and type I collagen COL1A1 (COL I) gene
expression of the annulus fibrosus (AF) and nucleus pulposus (NP) 2
weeks after Link N or saline injections. Gene expression was
measured by RT-PCR. GAPDH was used as a housekeeping gene
and served to normalize the results. Values represent the mean ±
standard deviation of Link N-injected discs normalized to saline-
treated discs (*P < 0.001).
Figure 3 Changes in MMP-3, ADAMTS-4, and ADAMTS-5 gene
expression. Changes in MMP-3, ADAMTS-4, and ADAMTS-5 gene
expression of the annulus fibrosus (AF) and nucleus pulposus (NP) 2
weeks after Link N or saline injections. Gene expression was
measured by RT-PCR. GAPDH was used as a housekeeping gene
and served to normalize the results. Values represent the mean ±
standard deviation of Link N-injected discs normalized to saline-
treated discs (*P < 0.001).
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acid degradation and loss. Hyaluronic acid levels were
higher in the AF than the NP, but levels were not
affected by treatment (Figure 4). These changes were
not statistically significant.
Histology
In order to examine the effect of Link N on the IVD
matrix, discs were studied histologically by Safranin O
staining, which detects the chondroitin sulfate chains of
aggrecan. Red Safranin O staining was present in the AF
and the vertebral growth plates in the control group
(Figure 5a). The NP was rounded, and distinct from the
AF. The Safranin O-stained histologic sections in the
saline-treated group showed signs of early degeneration,
with the NP being indistinct from the AF and with wavy
fibrocartilage lamellae and associated fibrochondrocytes
being apparent (Figure 5b). In contrast, in the Link N-
treated group, the NP consisted of numerous large,
vacuolated cells and smaller chondrocyte-like cells that
often appeared in clusters (Figure 5c).
Discussion
Previous studies have shown that Link N can act as a
growth factor and stimulate the synthesis of proteogly-
cans and collagens in articular cartilage [29,32-34], as
well as bovine IVD cells in vitro [30]. The present data
indicate that there is a trend towards Link N stimulating
the proteoglycan content when it is administered to the
degenerate rabbit disc in vivo. This stimulation occurs
in both the NP and AF of the disc and in the absence of
any effect on cell division. In addition to stimulating
aggrecan gene expression, Link N is also able to down-
regulate metalloproteinase gene expression in the degen-
erate disc. These are features needed for any agent
designed to stimulate disc repair. In principle, therefore,
Link N supplementation could be a viable option for
treating disc degeneration during its early stages while
the AF is intact. An intact AF is essential for optimal
repair in order to prevent the protrusion of the NP due
to the increased swelling potential associated with pro-
teoglycan accumulation.
One exception to the downregulation of proteolytic
activity by Link N was observed in the NP for
ADAMTS-5, where gene expression was increased. At
first sight this is not what one would predict for repair,
and it remains to be seen whether increased expression
is detrimental or not. Repair involves remodeling of the
disc ECM, however, and remodeling involves proteolysis.
Hence there is no need for a complete absence of pro-
teolysis during repair, as long as the matrix synthesis
exceeds turnover.
The proteoglycan changes observed with Link N are
similar to those reported after 12 weeks when the same
concentration of osteogenic protein-1 (OP-1) was
injected into the degenerate rabbit disc [22]. The
injected discs in the Link N group also display a similar
trend in disc height changes to that produced by OP-1
[22]. Link N thus appears to be effective at stimulating
repair of the IVD in vivo. One major advantage of Link
N over a growth factor such as OP-1 for therapeutic use
is the large saving in cost. Link N costs $750 for 50 mg,
which is about $1.5 per 100 μg injected in the rabbit. In
contrast, OP-1 costs $600 per 100 μg. Link N therefore
represents a potential economical therapeutic agent with
beneficial effects. However, a longer time frame follow-
ing Link N administration will be necessary to truly
prove the value of Link N and to determine whether its
beneficial effect can be sustained. In addition, it is not
clear to what degree the proteoglycan content of the
disc must be improved in order to influence disc func-
tion, and it may be necessary to use additional techni-
ques to ensure functional repair.
Despite the significant impairment associated with
degenerative disc disease, a clear understanding of its
Figure 4 Changes in DNA, proteoglycan (sulfated
glycosaminoglycan) and hyaluronic acid content. Changes in
DNA, proteoglycan (sulfated glycosaminoglycan (GAG)) and
hyaluronic acid (HA) contents of the annulus fibrosus (AF) and
nucleus pulposus (NP) in nonpunctured control discs and 12 weeks
after Link N or saline injections. Values represent the mean ±
standard deviation of Link N and saline-injected discs and
nonpuncture discs at 12 weeks post injection. There is a trend
towards Link N stimulating GAG and HA production but it is
statistically not significant (repeated analysis of variance, P > 0.8).
The injection of Link N did not affect the DNA contents in the NP
and AF.
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pathogenesis is still lacking. Currently, no animal model
parallels the complex nature of human disc degeneration
due to variation in disc composition and time course of
progression [39-41]. An animal model, however, is
essential to test the efficiency of disc repair. Several
models of induced or spontaneous disc degeneration
have been used in the past, but each type of model has
limitations [39-41]. One issue is the difficulty of using
small animals such as rodents because of the small size
and volume of their discs. In addition, the NPs cells
remain notochordal in the adult, unlike the human and
many large animal models. On the other hand, larger
animals, such as dog and sheep, are very expensive and
not appropriate to establish new experimental condi-
tions, although they are useful for testing approaches
established in smaller animal models. The rabbit IVD
aspiration model used in the present study represents a
compromise between the size of the animal, disc com-
position, and the cost of the experiments. It has been
used for its reproducibility in creating mild degeneration
and utility for evaluating treatment efficacy [21,35].
For biological repair of the degenerative IVD to be
successful in humans, it will probably be essential to
perform treatment early in the degenerative process,
before major damage to the collagen framework has
occurred. It will therefore be essential to determine
whether Link N can stimulate repair of the degenerated
human IVD in Thomson grade 2 and grade 3 discs [42].
While such treatment may not be able to fully repair
disc degeneration, it should be able to retard its progres-
sion and so delay the need for more aggressive surgical
intervention. To better understand the effect of Link N,
further studies on the mechanisms of action of this pep-
tide, including the receptors with which it interacts and
the intracellular signaling pathways that it transduces,
will be necessary. Ultimately, these studies should lead
to clinical trials on the repair of the NP in the degener-
ated IVD using Link N.
Conclusions
Link N can stimulate proteoglycan production in vivo in
both the NP and AF when it is administered to the
degenerate disc. Interestingly, the changes in proteogly-
can synthesis with Link N are similar to those reported
previously with the same concentration of OP-1. In
addition to stimulating the synthesis of aggrecan, Link
N is also able to downregulate metalloproteinase expres-
sion in the degenerate disc. These are features needed
for any agent designed to stimulate disc repair. In prin-
ciple, therefore, Link N supplementation could be a
viable option for treating disc degeneration. However, a
longer time frame following Link N administration will
be necessary to truly prove the therapeutic value of Link
N and show that it can actually restore the functional
properties of the disc. If Link N administration is to be
successful in humans, it will have to be performed early
Figure 5 Histologic changes after injection of saline or Link N. Safranin O-stained sections of control (nonpunctured), saline-treated, and
Link N-treated discs comparing the degree of degeneration. In comparison with the saline-treated group, the Link N group displayed a
restoration of the nucleus pulposus (NP) with the presence of intensely stained matrix and large cells typical of a control nucleus pulposus. AF,
annulus fibrosus; GP, growth plate.
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in the degenerative process before major damage to the
collagen framework has occurred. While such treatment
may not be able to fully repair disc degeneration, it
should be able to retard its progression and so delay the
need for more aggressive surgical intervention.
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